25 Feb 2013
(MENAFN) Gulf Pharmaceutical Industries (Julphar) announced that 2012’s profit climbed by 17.6 percent to USD54.50 million, reported Khaleej Times.
Meanwhile, operating profit went up by 8.6 percent from a year before to USD59.12 million.
The company added that gross profit grew by 11.1 percent in the year, reaching USD189.85 million, while operating profit margin was at 18.4 percent.
It is worth noting that Julphar’s sales revenue climbed by 15.3 percent from 2011, reaching USD321 million, as tender market sales increased by 22.5 percent.
02 Jul 2025
BBK launches the largest-ever Al Hayrat Prizes, offering BD 5 million to over 2,000 winners
12 May 2025
Alsharifi: “Proud of our strategic partnership with the Royal Humanitarian Foundation”
04 May 2025
BBK offers exclusive Mortgage Loans for luxury villas and apartments on Reef Island
30 Apr 2025
BBK discloses its financial results for the first quarter ended 31st March 2025
25 Mar 2025
BBK’s General Assembly Approves 35% Cash Dividend Distribution to Shareholders
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more